Загрузка страницы
Все видеоНовые видеоПопулярные видеоКатегории видео

Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

Randomized Phase II US Intergroup Study ECOG-ACRIN E1412 Grzegorz S. Nowakowski, MD Mayo Clinic #BCellMalignancies #AdvancedSolidTumors #Cancer #Research

Link To FULL Video:
https://www.oncologytube.com/video/39787/grzegorz-s.-nowakowski-md-gregnowakowski-gregnowakowski-mayoclinic-bcellmalignancies-advancedsolidtumors-cancer-research-randomized-phase-ii-us-intergroup-study-ecog-acrin-e1412

Видео Randomized Phase II US Intergroup Study ECOG-ACRIN E1412 канала OncologyTube
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
13 февраля 2021 г. 4:41:03
00:02:21
OncologyTube
Теги
Правообладателям
Жалоба
Комментарии
Другие видео канала
LBA-1 Driver Mutation Acquisition in Utero and ChildhoodLBA-1 Driver Mutation Acquisition in Utero and ChildhoodTiming, number, and type of sexual partners associated with risk of oropharyngeal cancerTiming, number, and type of sexual partners associated with risk of oropharyngeal cancerASCO 2021 Highlights in Breast Cancer Aditya Bardia, MDASCO 2021 Highlights in Breast Cancer Aditya Bardia, MDBlastic Plasmacytoid Dendritic Cell NeoplasmBlastic Plasmacytoid Dendritic Cell NeoplasmReal World Outcomes and Prognostication of Older PCNSL in the Contemporary EraReal World Outcomes and Prognostication of Older PCNSL in the Contemporary EraLiquid biopsies timely and effective testing method for NSCLC patients in CanadaLiquid biopsies timely and effective testing method for NSCLC patients in CanadaPostmenopausal Women With Early-stage Breast Cancer and Low Recurrence ScorePostmenopausal Women With Early-stage Breast Cancer and Low Recurrence ScoreEuropean Commission Approves Avelumab for mUCEuropean Commission Approves Avelumab for mUCLung-Map Translational Discoveries Shared At 2020 World Conference On Lung CancerLung-Map Translational Discoveries Shared At 2020 World Conference On Lung CancerSY-1425, a Potent and Selective RARα AgonistSY-1425, a Potent and Selective RARα AgonistAmivantamab, an EGFR-MET bispecific antibody, in combination with lazertinib in advanced EGFR NSCLCAmivantamab, an EGFR-MET bispecific antibody, in combination with lazertinib in advanced EGFR NSCLCVS-6766, a unique inhibitor of the RAF/MEK signaling pathway for patients with KRAS mutant tumorsVS-6766, a unique inhibitor of the RAF/MEK signaling pathway for patients with KRAS mutant tumorsA phase 1 study of AMG 757A phase 1 study of AMG 757ASCO 2024: Impact of Latino Ethnicity on Gut Microbiome in mRCC Regina Barragan-Carillo, PhdASCO 2024: Impact of Latino Ethnicity on Gut Microbiome in mRCC Regina Barragan-Carillo, PhdNew Data For In Metastatic, Squamous Cell Carcinoma Of The LungNew Data For In Metastatic, Squamous Cell Carcinoma Of The LungASCO 2021 Highlights in Colorectal Cancer and Gastrointestinal Cancer David Illson, MDASCO 2021 Highlights in Colorectal Cancer and Gastrointestinal Cancer David Illson, MDMedical Marijuana associated with fewer hospitalizations for individuals with sickle cell diseaseMedical Marijuana associated with fewer hospitalizations for individuals with sickle cell diseaseIbrutinib U.S. Prescribing Information Updated to Include Long-Term Data for WMIbrutinib U.S. Prescribing Information Updated to Include Long-Term Data for WMDevimistat Receives FDA Fast Track Designation for AMLDevimistat Receives FDA Fast Track Designation for AMLDaratumumab‐lenalidomide‐dexamethasone vs standard‐of‐care regimensDaratumumab‐lenalidomide‐dexamethasone vs standard‐of‐care regimens
Статистика портала
Яндекс.Метрика
© 2008-2024 «Информационно-развлекательный портал города Верхняя Салда»
| Карта портала | Реклама | Контакты | Сообщить об ошибке | Соглашения
salda.ws salda.ws@mail.ru
Сейчас на сайте: 512 Статистика портала